Tamoxifen or Raloxifen for chemoprevention of breast cancer in high risk women: The NSABP-experience

被引：0
|
作者：
Wickerham, D. L. [1 ]
机构：
[1] NASBP, Pittsburgh, PA USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(08)70212-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S20
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] Australian clinicians and chemoprevention for women at high familial risk for breast cancer
    Keogh, Louise A.
    Hopper, John L.
    Rosenthal, Doreen
    Phillips, Kelly-Anne
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2009, 7
  • [32] Chemoprevention of breast cancer for mutation carriers and other high risk women
    Decensi, A.
    Puntoni, M.
    BREAST, 2009, 18 : S4 - S5
  • [33] Chemoprevention of breast cancer with tamoxifen and raloxifene
    Weiss, JM
    Diedrich, K
    Ortmann, O
    GYNAKOLOGE, 2003, 36 (02): : 97 - 102
  • [34] Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among US Women
    Waters, Erika A.
    Cronin, Kathleen A.
    Graubard, Barry I.
    Han, Paul K.
    Freedman, Andrew N.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) : 443 - 446
  • [35] Baseline Mammographic Breast Density and the Risk of Invasive Breast Cancer in Postmenopausal Women Participating in the NSABP Study of Tamoxifen and Raloxifene (STAR)
    Cecchini, Reena S.
    Costantino, Joseph P.
    Cauley, Jane A.
    Cronin, Walter M.
    Wickerham, D. Lawrence
    Bandos, Hanna
    Weissfeld, Joel L.
    Wolmark, Norman
    CANCER PREVENTION RESEARCH, 2012, 5 (11) : 1321 - 1329
  • [36] Effects of tamoxifen on benign breast disease in women at high risk for breast cancer
    Tan-Chiu, E
    Wang, JP
    Costantino, JP
    Paik, S
    Butch, C
    Wickerham, DL
    Fisher, B
    Wolmark, N
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04) : 302 - 307
  • [37] Decision-making and experience of tamoxifen as chemoprevention to manage breast cancer risk for young women with a BRCA1/2 mutation
    Forrest, L. E.
    Shepherd, R. Forbes
    Young, M.
    Keogh, L. A.
    James, P. A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 721 - 721
  • [38] Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older
    Freedman, Andrew N.
    Yu, Binbing
    Gail, Mitchell H.
    Costantino, Joseph P.
    Graubard, Barry I.
    Vogel, Victor G.
    Anderson, Garnet L.
    McCaskill-Stevens, Worta
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : 2327 - 2333
  • [39] Psychological implications of tamoxifen treatment in women at high risk to breast cancer
    Fallowfield, L
    SCIENTIFIC BASES OF CANCER CHEMOPREVENTION, 1996, 1120 : 219 - 225
  • [40] Acceptance of tamoxifen chemoprevention by physicians and women at risk
    McKay, A
    Latosinsky, S
    Martin, W
    CANCER, 2005, 103 (01) : 209 - 210
12345